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Purpose: To evaluate the ability of a new center-distance low-add soft contact lens 
(Proclear EP) to relief symptoms of asthenopia in non-presbyopes (30 to 40 years of age) 
and early presbyopes (age 40 to 45 years of age).  
 
Method: Forty-one patients (66% women) were enrolled in the study and distributed among 
4 clinical groups randomly assigned to a new multifocal low-add soft contact lens (Proclear 
EP; n=21) or a single vision (SV) lenses (Proclear Compatibles; n=20) as placebo. 
Accommodative function was recorded continuously while the patient was looking at a 
Maltese Cross placed at 66, 38 and 25 cms. LogMAR visual acuity (Precision Vision, USA) 
and subjective information regarding visual discomfort and symptoms of asthenopia 
associated to near vision tasks was obtained. Follow-up visits were scheduled at 1 week and 
1 month after lens delivery.  
 
Results: Visual acuity was comparable between Proclear EP and SV lens. End-of-day visual 
discomfort and tiredness was significantly ameliorated by Proclear EP compared with SV 
lenses in non-presbyopes while a similar trend, although not statistically significant was 
observed in the early presbyopes. Asthenopia symptoms improved by 8.33% and 9.38% in 
the non-presbyopes and early presbyopes wearing Proclear EP, respectively.  The 
improvement with SV lenses was 5 and 2.5%, respectively. 
 
Conclusions: Proclear EP produced a significantly higher relief of asthenopia and visual 
discomfort symptoms compared to control groups wearing single vision lenses acting as 
placebo. Visual acuity with Proclear was comparable under high and low contrast conditions 
to that of SV lenses.  
 
Disclosure: The present study has been partially funded by Coopervision.  
 
 
